Back to Journals

Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy


Professor Zou

Vice Chairman, Department of Medicine, Warren, University of Oklahoma Health Science Center, United States

Professor Zou

Editor-in-Chief: Professor Ming Zou

Dr Zou is professor of biomedical sciences, director at the Center of Molecular and Translational Medicine and associate vice president for research at Georgia State University.

Dr Zou earned his medical degree at the Hubei Medical University at Xianning, China and his PhD degree in the University of Konstanz, Germany. He worked as assistant professor in the Boston University School of Medicine and associate professor in the University of Tennessee. He became professor of biochemistry and medicine in the University of Oklahoma Health Science Center in 2006. 

Dr Zou has served on several national and international study panels such as the National Institutes of Health, American Diabetes Association, American Heart Association, Chinese National Science Foundation, etc. In 2008 he was elected to the American Society for Clinical Investigation, membership in which reflects accomplishments by its members at an early stage in their careers and one of the United States’ oldest honor societies of physician-scientists.
 
Dr Zou is recognized internationally as an expert in diabetes and diabetes-related cardiovascular complications. He is the author of more than 100 journal articles and book chapters. He is the editorial members for over ten journals and reviewer for over 30 journals, including Diabetes, the Journal of Clinical Investigation, Journal of Biological Chemistry, Circulation, Circulation Research, and the New England Journal of Medicine.


Dr Abcouwer

Dr Abcouwer

Associate Editor: Steven F. Abcouwer

Dr. Abcouwer is currently a Professor of Ophthalmology and Visual Sciences at the University of Michigan Medicine Kellogg Eye Center. He trained as a chemical engineer at the University of Missouri-Columbia, specializing in biochemical engineering during PhD training at the University of Houston. He gravitated toward biomedical research as he conducted postdoctoral training at Monsanto Heath Sciences, studying therapeutic approaches to inhibit tumor invasion and metastasis. As a junior faculty member at Harvard Medical School Department of Surgery at the Massachusetts General Hospital he cloned a novel human glutaminase gene and identified the regulatory elements in the rat glutamine synthetase gene. Then, as a faculty member at the University of New Mexico School of Medicine, Department of Biochemistry and Molecular Biology he discovered the role of activating transcription factor 4 in regulation of vascular endothelial growth factor (VEGF) gene expression. While at Penn State University College of Medicine, Departments of Surgery, Ophthalmology and Physiology he studied neuronal death mechanisms and conducted preclinical testing of therapeutics in rodent models of diabetic retinopathy. He joined the University of Michigan in 2010. He is currently Co-Principal Investigator of two National Eye Institute-funded R01 research grants exploring pathological mechanisms of diabetic retinopathy, is Co-Principal Investigator for a National Institute of Diabetes, Digestive and Kidney Diseases-funded R24 grant examining metabolic changes in diabetic complications-prone tissues caused by diabetes, is Principal Investigator for several research contracts with pharmaceutical companies and is the Director of the Molecular Biology Module of the National Eye Institute-funded Kellogg Eye Center Vision Research Core Facility. Dr. Abcouwer has sat on numoersour national and international grant review committes and is currently is a regular member of the National Institutes of Heath Diseases and Pathophysiology of the Visual System Study Section. He serves on the editorial board of several scientific journals. His current research interests include neurodegeneration and vascular dysfunction in diabetic retinopathy, the role of inflammation in retinal vascular dysfunction, and mechanisms controling retinal vascular develoment.


Prof. Dr. Cheng

Medical Sciences, Chang Jung Christian University, Taiwan

Prof. Dr. Cheng


Dr Tziomalos

Department of Internal Medicine, Aristotle University of Thessaloniki, Greece

Dr Tziomalos

Associate Editor (Greece): Doctor Konstantinos Tziomalos 

Doctor Tziomalos is Assistant Professor of Internal Medicine at the Aristotle University of Thessaloniki, Greece. He served as a Clinical Research Fellow at the Department of Clinical Biochemistry (Vascular Prevention Clinic), University College London Medical School, UK and completed a post-doctorate at the Stem Cell Institute and Cardiovascular Research Laboratory, University of Miami, USA. His research interests include dyslipidemia, stroke and cardiovascular disease prevention. He has authored more than 250 peer-reviewed scientific articles, which have received more than 4700 citations.


Editorial Board

Eman Alissa, Clinical Biochemistry Department, Faculty of Medicine, King Abdulaziz University, Saudi Arabia

Julien S Baker, Professor, Director of Research, Institute of Clinical Exercise and Health Science, Applied Physiology Research Laboratory, School of Science and Sport, University of the West of Scotland, Scotland

Abdulbari Bener, Advisor to WHO, Professor of Public Health, Dept. of Biostatistics & Medical Informatics, Cerrahpaşa Faculty of Medicine, Istanbul University, Turkey

Juei-Tang Cheng, PhD. Chair-Professor in Graduate Institute of Medical Science, College of Health Science, Chang Jung Christian University, Tainan City, Taiwan.

Baptist Gallwitz, Professor, Deputy Director, Medical Clinic IV, University Hospital Tübingen, Tübingen, Germany

Claes-Göran Östenson, Professor of Endocrinology, Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.

Amer Rajab, Department of Surgery, Ohio State University Medical Center, Columbus, Ohio, USA

Amy Jo Riggs, Health and Kinesiology Department, Georgia Southern University, GA, USA

Kerry Stewart, Professor of Medicine, Director, Clinical and Research Exercise Physiology, John Hopkins University School of Medicine, MD, USA

Chaowu Xiao, Adjunct Professor, Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Canada

Wen-Zhu Yang, Lethbridge Research Centre, Agriculture and Agri-Food Canada, Canada

Allan Z. Zhao, Ph.D., Member, the National 1000 Talents Program; Distinguished Professor, The Institute of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Guangzhou, Guangdong Province, People's Republic of China